Lonza Group Ltd
Lonza Group AG, together with its subsidiaries, supplies various products and services for pharmaceutical, biotech, and nutrition markets in Europe, North and Central America, Latin America, Asia, Australia, New Zealand, and internationally. It operates through Biologics; Small Molecules; Cell & Gene; and Capsules & Health Ingredients segments. The Biologics segment engages in the contract develo… Read more
Lonza Group Ltd (LZAGF) - Total Assets
Latest total assets as of December 2025: $18.97 Billion USD
Based on the latest financial reports, Lonza Group Ltd (LZAGF) holds total assets worth $18.97 Billion USD as of December 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Lonza Group Ltd - Total Assets Trend (2004–2025)
This chart illustrates how Lonza Group Ltd’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Lonza Group Ltd - Asset Composition Analysis
Current Asset Composition (December 2025)
Lonza Group Ltd's total assets of $18.97 Billion consist of 42.2% current assets and 57.8% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 3.8% |
| Accounts Receivable | $1.74 Billion | 9.2% |
| Inventory | $1.68 Billion | 8.9% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $329.00 Million | 1.7% |
| Goodwill | $1.96 Billion | 10.3% |
Asset Composition Trend (2004–2025)
This chart illustrates how Lonza Group Ltd's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Lonza Group Ltd's current assets represent 42.2% of total assets in 2025, an increase from 35.5% in 2004.
- Cash Position: Cash and equivalents constituted 3.8% of total assets in 2025, up from 1.2% in 2004.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 11.0% of total assets, an increase from 2.0% in 2004.
- Asset Diversification: The largest asset category is goodwill at 10.3% of total assets.
Lonza Group Ltd Competitors by Total Assets
Key competitors of Lonza Group Ltd based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Lonza Group Ltd - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Lonza Group Ltd generates 0.34x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Moderate ROA - For every $100 in assets, Lonza Group Ltd generates $ 5.00 in net profit.
Lonza Group Ltd - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.24 | 1.52 | 1.55 |
| Quick Ratio | 1.77 | 1.04 | 1.18 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $4.43 Billion | $ 1.86 Billion | $ 1.70 Billion |
Lonza Group Ltd - Advanced Valuation Insights
This section examines the relationship between Lonza Group Ltd's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 3.98 |
| Latest Market Cap to Assets Ratio | 2.20 |
| Asset Growth Rate (YoY) | -3.9% |
| Total Assets | $18.97 Billion |
| Market Capitalization | $41.73 Billion USD |
Valuation Analysis
Premium Asset Valuation: The market values Lonza Group Ltd's assets at a significant premium ( 2.20x), suggesting investors see substantial growth potential or unique competitive advantages.
Slight Asset Contraction: Lonza Group Ltd's assets decreased by 3.9% over the past year, which may reflect streamlining or optimization of resources.
Annual Total Assets for Lonza Group Ltd (2004–2025)
The table below shows the annual total assets of Lonza Group Ltd from 2004 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-12-31 | $18.97 Billion | -3.88% |
| 2024-12-31 | $19.73 Billion | +17.12% |
| 2023-12-31 | $16.85 Billion | -2.93% |
| 2022-12-31 | $17.36 Billion | +5.45% |
| 2021-12-31 | $16.46 Billion | +14.07% |
| 2020-12-31 | $14.43 Billion | +4.25% |
| 2019-12-31 | $13.84 Billion | -0.57% |
| 2018-12-31 | $13.92 Billion | +0.95% |
| 2017-12-31 | $13.79 Billion | +101.96% |
| 2016-12-31 | $6.83 Billion | +9.28% |
| 2015-12-31 | $6.25 Billion | -3.00% |
| 2014-12-31 | $6.44 Billion | -1.53% |
| 2013-12-31 | $6.54 Billion | -7.87% |
| 2012-12-31 | $7.10 Billion | +1.14% |
| 2011-12-31 | $7.02 Billion | +46.92% |
| 2010-12-31 | $4.78 Billion | -3.36% |
| 2009-12-31 | $4.94 Billion | +0.24% |
| 2008-12-31 | $4.93 Billion | -0.38% |
| 2007-12-31 | $4.95 Billion | +26.56% |
| 2006-12-31 | $3.91 Billion | -9.67% |
| 2005-12-31 | $4.33 Billion | +29.63% |
| 2004-12-31 | $3.34 Billion | -- |